Device Trial Radar · NCT07124390
Electroacupuncture as a Treatment for Refractory Overactive Bladder
Last checked: Nov 19, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
24
Planned (sponsor's estimate)
Start
Aug 15, 2026
Primary completion
Nov 30, 2027
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- Chelsea and Westminster NHS Foundation TrustAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Imperial College London
- First posted
- Aug 15, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a single-site feasibility randomised controlled trial evaluating the feasibility and acceptability of electroacupuncture (EA), and percutaneous tibial nerve stimulation (PTNS), in women with refractory overactive bladder (OAB) who have not achieved satisfactory improvement following standard pelvic health physiotherapy. The primary aim is to determine whether a larger definitive trial is feasible by assessing recruitment, consent, retention, treatment adherence, data completeness, intervention delivery, safety, and participant acceptability. Twenty-four participants will be randomly allocated to receive electroacupuncture or PTNS, over a 12-week treatment period. Outcome assessments will be completed at baseline, 6 weeks, 12 weeks, 6 months, and 12 months. The findings will inform the design of a future definitive randomised controlled trial and contribute to the evidence base for non-pharmacological treatment options for overactive bladder.
Conditions
- Over Active Bladder
- Urinary Incontinence (UI)
- Nocturia
Interventions
Name: Electroacupuncture (EA) Type: Device-based acupuncture therapyDevice
Description: Insertion of acupuncture needles at specific points with electrical stimulation (20 Hz) for 30 minutes per session.
Neuromodulation therapyDevice
Type: Neuromodulation therapy Description: Insertion of a needle electrode near the medial malleolus with low-voltage electrical stimulation (20 Hz) applied for 30 minutes per session.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency and Severity of Adverse EventsTime frame: Baseline, during each treatment session, 6 weeks, 12 weeks, and throughout study participation up to 12 weeks after randomisation.
- Recruitment RateTime frame: At completion of recruitment (anticipated recruitment period: Sept 2026 to March 2027.
- Participant Retention and Follow-up Completion Rate.Time frame: 6 weeks, 12 weeks, 6 months, and 12 months after randomisation.
2 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Chelsea and Westminster hospital NHS foundation Trust
London, United Kingdom, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.